PTC Therapeutics | PTCT - Stock



PTC Therapeutics reported $34.06M in Stock for its fiscal quarter ending in June of 2025.


Stock Change Date
Acadia Pharmaceuticals USD 26.12M 3.18M Jun/2025
Alnylam Pharmaceuticals USD 71.69M 6.11M Jun/2025
Amgen USD 6.58B 146M Jun/2025
Biogen USD 2.27B 400K Jun/2025
BioMarin Pharmaceutical USD 1.34B 65.32M Jun/2025
Cytokinetics 0 0 Dec/2023
Daiichi Sankyo JPY 514.91B 39.56B Mar/2025
Gilead Sciences USD 1.83B 66M Jun/2025
Incyte USD 83.42M 19.45M Jun/2025
Ionis Pharmaceuticals USD 8.48M 3.02M Jun/2025
Ironwood Pharmaceuticals USD 0 0 Dec/2020
Novartis USD 6.31B 478M Jun/2025
Pfizer USD 11.67B 817M Jun/2025
PTC Therapeutics USD 34.06M 12.39M Jun/2025
Roche Holding CHF 7.61B 339M Dec/2024
Sarepta Therapeutics USD 994.04M 52.6M Jun/2025
TG Therapeutics 155.2M 2.56M Jun/2025
Ultragenyx Pharmaceutical USD 46.5M 467K Jun/2025
Vertex Pharmaceuticals USD 1.5B 139.6M Jun/2025
Xencor USD 0 0 Jun/2020